Boryung Future Growth
Future criteria checks 2/6
Boryung is forecast to grow earnings and revenue by 12.1% and 12.4% per annum respectively. EPS is expected to grow by 10.9% per annum. Return on equity is forecast to be 11.4% in 3 years.
Key information
12.1%
Earnings growth rate
10.9%
EPS growth rate
Pharmaceuticals earnings growth | 36.0% |
Revenue growth rate | 12.4% |
Future return on equity | 11.4% |
Analyst coverage | Low |
Last updated | 06 Nov 2024 |
Recent future growth updates
Recent updates
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt
Sep 20Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,312,000 | 82,000 | N/A | 72,000 | 1 |
12/31/2025 | 1,173,200 | 69,800 | N/A | 70,000 | 1 |
12/31/2024 | 1,041,000 | 64,900 | N/A | 131,000 | 1 |
9/30/2024 | 991,430 | 61,995 | 57,035 | 79,934 | N/A |
6/30/2024 | 928,718 | 64,579 | 40,051 | 63,399 | N/A |
3/31/2024 | 889,416 | 52,254 | 51,610 | 78,166 | N/A |
12/31/2023 | 859,626 | 40,203 | 19,169 | 42,224 | N/A |
9/30/2023 | 829,854 | 28,267 | -120,022 | -3,357 | N/A |
6/30/2023 | 819,463 | 38,284 | -75,467 | 43,689 | N/A |
3/31/2023 | 785,679 | 42,063 | -94,393 | 24,794 | N/A |
12/31/2022 | 760,476 | 41,894 | -95,181 | 27,814 | N/A |
9/30/2022 | 724,659 | 53,911 | 2,909 | 66,442 | N/A |
6/30/2022 | 694,170 | 52,524 | -37,854 | 22,893 | N/A |
3/31/2022 | 661,948 | 34,380 | -24,301 | 37,032 | N/A |
12/31/2021 | 627,279 | 43,044 | 957 | 60,167 | N/A |
9/30/2021 | 600,008 | 41,823 | 31,493 | 51,816 | N/A |
6/30/2021 | 587,350 | 28,892 | -1,699 | 56,164 | N/A |
3/31/2021 | 571,594 | 38,370 | 4,515 | 58,667 | N/A |
12/31/2020 | 561,867 | 26,856 | -10,655 | 44,741 | N/A |
9/30/2020 | 562,433 | 27,744 | -7,870 | 46,515 | N/A |
6/30/2020 | 546,974 | 27,969 | 25,017 | 46,561 | N/A |
3/31/2020 | 539,742 | 31,678 | 9,933 | 35,068 | N/A |
12/31/2019 | 524,269 | 32,222 | -20,246 | 46,999 | N/A |
9/30/2019 | 498,006 | 32,950 | -31,145 | 57,203 | N/A |
6/30/2019 | 480,242 | 29,886 | -54,429 | 45,294 | N/A |
3/31/2019 | 467,445 | 22,830 | -55,631 | 47,848 | N/A |
12/31/2018 | 460,402 | 20,307 | -17,507 | 38,914 | N/A |
9/30/2018 | 441,580 | 64,630 | -45,289 | 24,718 | N/A |
6/30/2018 | 440,087 | 62,855 | N/A | 26,833 | N/A |
3/31/2018 | 434,565 | 60,451 | N/A | -12,386 | N/A |
12/31/2017 | 422,721 | 56,699 | N/A | -24,614 | N/A |
9/30/2017 | 426,554 | -3,202 | N/A | -31,392 | N/A |
6/30/2017 | 423,777 | -2,977 | N/A | -33,281 | N/A |
3/31/2017 | 420,133 | 5,020 | N/A | 402 | N/A |
12/31/2016 | 409,140 | 5,614 | N/A | 9,363 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A003850's forecast earnings growth (12.1% per year) is above the savings rate (2.7%).
Earnings vs Market: A003850's earnings (12.1% per year) are forecast to grow slower than the KR market (29.5% per year).
High Growth Earnings: A003850's earnings are forecast to grow, but not significantly.
Revenue vs Market: A003850's revenue (12.4% per year) is forecast to grow faster than the KR market (9.2% per year).
High Growth Revenue: A003850's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A003850's Return on Equity is forecast to be low in 3 years time (11.4%).